Summary:
This is a randomized, placebo-controlled study to investigate the safety and tolerability of single oral doses of the investigational drug in healthy Japanese participants.
*Japanese Translators Are Available*
Qualified Participants Must:
Be of Japanese origin and have Japanese parents
Be Healthy
Be between 18 and 60 years of age
Qualified Participants May Receive:
Qualified participants may receive investigational study drug or placebo at no cost. Participants will be eligible to receive compensation and transportation can be provided at no cost.